Vir Biotechnology (VIR) PT Raised to $18 at Evercore ISI

February 24, 2026 5:47 AM EST Send to a Friend
Evercore ISI analyst Cory Kasimov raised the price target on Vir Biotechnology (NASDAQ: VIR) to $18.00 (from $12.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login